FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2026

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company's assets and liabilities measured at fair value on a recurring basis consist of derivative instruments and investment securities.


	March 31, 2026								December 31, 2025
	Level 1		Level 2		Level 3		Net Balance		Level 1		Level 2		Level 3		Net Balance
Assets
Derivatives	$	—	$	10	$	—	$	10	$	—	$	22	$	—	$	22
Investment securities	1,170		—		28		1,198		1,217		—		24		1,241
Total assets	1,170		10		28		1,208		1,217		22		24		1,263

Liabilities
Derivatives	—		(38)		—		(38)		—		(33)		—		(33)
Total liabilities	$	—	$	(38)	$	—	$	(38)	$	—	$	(33)	$	—	$	(33)

Schedule of Investment Securities Classified as Available for Sale


	March 31, 2026								December 31, 2025
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Investment securities (1)
Non-U.S. debt securities (2)	$	28	$	—	$	—	$	28	$	24	$	—	$	—	$	24
Equity securities	581		629		(40)		1,170		578		666		(27)		1,217
Total	$	609	$	629	$	(40)	$	1,198	$	602	$	666	$	(27)	$	1,241

(1)Net gains (losses) recorded to earnings related to these securities were $(50) million and $(140) million for the three months ended March 31, 2026 and 2025.

(2)As of March 31, 2026, the Company's non-U.S. debt securities are classified as available for sale securities and mature within one year.

Schedule of Derivatives

The table below summarizes the fair value of all derivatives, including hedging instruments and embedded derivatives.


	March 31, 2026				December 31, 2025
	Assets		Liabilities		Assets		Liabilities
Derivatives accounted for as hedges

Interest rate swap contracts	$	—	$	(24)	$	9	$	(24)

Derivatives not accounted for as hedges
Currency exchange contracts and other	10		(14)		13		(9)


Total derivatives	$	10	$	(38)	$	22	$	(33)